Tuesday, May 6, 2025
Home Tags APHEX

Tag: APHEX

Superbug News - CoronaVirus Watch List

Aphex BioCleanse (SNST) Making Serious Headlines.

Editor / Curator -
Aphex Biocleanse Systems
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Further Expands Distribution Channels.

Editor / Curator -
Dermaphex
Superbug News - CoronaVirus Watch List

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
Aphex
CoronaVirus

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
Aphex BioCleanse
Biotech News

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Photos: Aphex BioCleanse Systems.

Editor / Curator -
APHX, APHEX
Biotech News

Aphex BioCleanse Systems Inc, Expands Sanitizer Production at its New Manufacturing...

Editor / Curator -
12Page 1 of 2

Latest article

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

All News Editor / Curator -
Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.